Ocuphire Pharma
safety findings across all arms | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
87 of 114
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Results
June 2021
secondary safety findings | Ocuphire Pharma
Related slides by other companies
AstraZeneca
Investor Event
September 2024
regimen generally well tolerated | AstraZeneca
AstraZeneca
Investor Event
September 2024
common aes in line with known profile for the regimen | AstraZeneca
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights